Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BRISTOL-MYERS-SQUIBB-COMP-11877/news/Bristol-Myers-Squibb-Receives-Positive-CHMP-Opinion-for-CAR-T-Cell-Therapy-Abecma-idecabtagene-vicl-45821363/?utm_source=whatsapp&utm_medium=social&utm_campaign=share